Compare Degarelix (evidence A) and Oxytocin (evidence A) on mechanism, clinical status, safety, and dosing.
Degarelix is a synthetic GnRH antagonist (MW ~1632.3 g/mol) and the first injectable GnRH receptor blocker approved for advanced prostate cancer. FDA-approved…
Oxytocin is an endogenous cyclic nonapeptide hormone (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 with a disulfide bridge between Cys1 and Cys6, MW ~1007.2 g/mol)…